1. What are the first-line therapies recommended for gout flares according to the 2020 American College of Rheumatology Guideline?
2. How is the choice between colchicine, NSAIDs, and glucocorticoids determined in the management of gout flares?
3. What is the recommendation for using IL-1 inhibitors in patients with gout flares who cannot tolerate other anti-inflammatory therapies?
4. What is the preferred adjuvant treatment for gout flares, according to the guideline?
5. What lifestyle factors are conditionally recommended to be limited in patients with gout?
6. What is the recommendation regarding the use of vitamin C supplementation in patients with gout?
7. When should hydrochlorothiazide be switched to an alternate antihypertensive in patients with gout?
8. What is the recommended antihypertensive agent of choice for patients with gout?
9. What is the recommendation regarding low-dose aspirin in patients with gout who are taking it for appropriate indications?
10. What are the indications for initiating pharmacologic urate-lowering therapy (ULT) in patients with gout according to the guideline?